​

Bionano Genomics (BNGO) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BNGO Stock Forecast

Bionano Genomics (BNGO) stock forecast, based on 5 Wall Street analysts, predicts a 12-month average price target of $1.00, with a high of $1.00 and a low of $1.00. This represents a -80.54% decline from the last price of $5.14.

- $1 $2 $3 $4 $5 $6 High: $1 Avg: $1 Low: $1 Last Closed Price: $5.14

BNGO Stock Rating

Bionano Genomics stock's rating consensus is Buy, based on 5 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (60.00%), 2 Hold (40.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 5 0 2 3 Strong Sell Sell Hold Buy Strong Buy

BNGO Forecast vs Benchmarks

TypeNameUpside
StockBionano Genomics-80.54%
SectorHealthcare Stocks 25.20%
IndustryDiagnostics & Research Stocks16.01%

Price Target Trends

1M3M12M
# Anlaysts--2
Avg Price Target--$1.50
Last Closing Price$5.14$5.14$5.14
Upside/Downside---70.82%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jan, 25--4--4
Dec, 24-14--5
Nov, 24-24--6
Oct, 24123--6
Sep, 24223--7
Latest Price Target by Analysts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Aug 28, 2024Sung Ji NamScotiabank$1.00$0.5196.08%-80.54%
May 16, 2024Mark MassaroBTIG$2.00$1.1573.91%-61.09%
May 25, 2023Bionano Genomics'sEF Hutton$175.00$65.00169.23%3304.67%
Dec 12, 2022BTIG$350.00$219.0059.82%6709.34%
Latest Upgrade/Downgrade by Analysts
DateCompanyPrevious RatingNew RatingRating Change
Nov 18, 2024BTIGNeutralNeutralhold
Sep 10, 2024BTIGBuyNeutraldowngrade
Aug 28, 2024ScotiabankSector OutperformSector Performdowngrade
May 16, 2024BTIGBuyBuyhold
May 25, 2023EF HuttonBuyinitialise
Jan 05, 2023ScotiabankSector Outperforminitialise
Jan 25, 2021Odeon Capital Group LLCBuyBuyhold
Jan 16, 2021OppenheimerBuyBuyhold
Dec 30, 2020OppenheimerOutperformOutperformhold

Financial Forecast

EPS Forecast

$-650 $-510 $-370 $-230 $-90 $50 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-3.95$-2.62$-4.58$-6.81-----
Avg Forecast$-4.00$-2.48$-4.28$-396.73$-93.13$-18.57$-15.30$-4.80$6.00
High Forecast$-4.92$-3.05$-5.79$-645.24$-151.47$-30.21$-22.35$-7.81$4.07
Low Forecast$-3.32$-2.06$-3.48$-268.85$-63.11$-12.59$-8.46$-3.25$9.76
Surprise %-1.25%5.65%7.01%-98.28%-----

Revenue Forecast

$0 $50M $100M $150M $200M $250M Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$8.50M$17.98M$27.80M$36.12M-----
Avg Forecast$8.00M$17.26M$27.69M$35.97M$28.91M$30.69M$37.48M$101.63M$138.73M
High Forecast$6.95M$14.99M$23.72M$27.05M$28.61M$23.08M$28.19M$76.43M$104.33M
Low Forecast$9.42M$20.32M$35.22M$53.31M$29.12M$45.48M$55.54M$150.60M$205.58M
Surprise %6.25%4.19%0.42%0.40%-----

Net Income Forecast

$-25B $-19B $-13B $-7B $-1B $5B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-41.14M$-72.44M$-132.60M$-232.49M-----
Avg Forecast$-136.60M$-84.73M$-146.00M$-15.61B$-3.66B$-730.74M$-525.93M$-188.84M$204.90M
High Forecast$-168.08M$-104.26M$-197.69M$-22.04B$-5.17B$-1.03B$-763.12M$-266.60M$138.85M
Low Forecast$-113.22M$-70.23M$-118.84M$-9.18B$-2.16B$-429.85M$-288.75M$-111.08M$333.25M
Surprise %-69.89%-14.52%-9.18%-98.51%-----

BNGO Forecast FAQ

Is Bionano Genomics stock a buy?

Bionano Genomics stock has a consensus rating of Buy, based on 5 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 2 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Bionano Genomics is a favorable investment for most analysts.

What is Bionano Genomics's price target?

Bionano Genomics's price target, set by 5 Wall Street analysts, averages $1 over the next 12 months. The price target range spans from $1 at the low end to $1 at the high end, suggesting a potential -80.54% change from the previous close price of $5.14.

How does Bionano Genomics stock forecast compare to the average forecast of its sector, industry, and investment themes?

Bionano Genomics stock forecast shows a -80.54% downside, underperforming the average forecast for the healthcare stocks sector (25.20%) and underperforming the diagnostics & research stocks industry (16.01%).

What is the breakdown of analyst ratings for Bionano Genomics over the past three months?

  • January 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • December 2024: 0% Strong Buy, 20.00% Buy, 80.00% Hold, 0% Sell, 0% Strong Sell.
  • November 2024: 0% Strong Buy, 33.33% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.

What is Bionano Genomics’s EPS forecast?

Bionano Genomics's average annual EPS forecast for its fiscal year ending in December is -93.13 for 2024, a 1267.55% increase from the reported $-6.81 in 2023. The prediction for 2025 is $-18.57, $-15.3 for 2026, $-4.8 for 2027, and $6 for 2028.

What is Bionano Genomics’s revenue forecast?

Bionano Genomics's average annual revenue forecast for its fiscal year ending in December is $28.91M for 2024, a -19.96% decrease from the reported $36.12M in 2023. The forecast for 2025 is $30.69M, $37.48M for 2026, $101.63M for 2027, and $138.73M for 2028.

What is Bionano Genomics’s net income forecast?

For its fiscal year ending in December, Bionano Genomics's average annual net income forecast is $-3.664B for 2024, reflecting an 1476.00% increase from the reported $-232M in 2023. The projection for 2025 is $-731M, $-526M for 2026, $-189M for 2027, and $204.9M for 2028.